Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1119975.RAPZv2e4YnuLCjZdhPJxGeCc4PF9JGXErUIu0JBaQvH8Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1119975.RAPZv2e4YnuLCjZdhPJxGeCc4PF9JGXErUIu0JBaQvH8Q130_assertion type Assertion NP1119975.RAPZv2e4YnuLCjZdhPJxGeCc4PF9JGXErUIu0JBaQvH8Q130_head.
- NP1119975.RAPZv2e4YnuLCjZdhPJxGeCc4PF9JGXErUIu0JBaQvH8Q130_assertion description "[The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1119975.RAPZv2e4YnuLCjZdhPJxGeCc4PF9JGXErUIu0JBaQvH8Q130_provenance.
- NP1119975.RAPZv2e4YnuLCjZdhPJxGeCc4PF9JGXErUIu0JBaQvH8Q130_assertion evidence source_evidence_literature NP1119975.RAPZv2e4YnuLCjZdhPJxGeCc4PF9JGXErUIu0JBaQvH8Q130_provenance.
- NP1119975.RAPZv2e4YnuLCjZdhPJxGeCc4PF9JGXErUIu0JBaQvH8Q130_assertion SIO_000772 24131622 NP1119975.RAPZv2e4YnuLCjZdhPJxGeCc4PF9JGXErUIu0JBaQvH8Q130_provenance.
- NP1119975.RAPZv2e4YnuLCjZdhPJxGeCc4PF9JGXErUIu0JBaQvH8Q130_assertion wasDerivedFrom befree-2016 NP1119975.RAPZv2e4YnuLCjZdhPJxGeCc4PF9JGXErUIu0JBaQvH8Q130_provenance.
- NP1119975.RAPZv2e4YnuLCjZdhPJxGeCc4PF9JGXErUIu0JBaQvH8Q130_assertion wasGeneratedBy ECO_0000203 NP1119975.RAPZv2e4YnuLCjZdhPJxGeCc4PF9JGXErUIu0JBaQvH8Q130_provenance.